Support the Federal 'No Toxics in Food Packaging Act of 2026'

Everyone deserves access to food that is not packaged with toxic chemicals, regardless of where they live, or what they eat!  

BCPP is collaborating with Rep Schakowsky (D-IL) and Sen Blumenthal (D-CT) on a new federal bill that bans 3 groups of toxic chemicals and 12 substances directly linked to cancer or hormone disruption from materials that come into contact with food and beverage. This means materials used in production, processing and packaging, as well as cook & serving ware, bulk transport and re-usable containers.

More and more science is showing the chemicals to be banned by this bill are leaching from food packaging into food and then into people, contributing to increasing rates of breast cancer, reproductive harm, asthma, learning disabilities, and other serious diseases.

The bill will be introduced in the House and Senate in June 2026.  See below for more information on this bill.

NOTE: The list of NGOs and Businesses formally endorsing this legislation will be shared on websites and advocacy materials related to this bill by Rep. Schakowsky, BCPP, and others.

This endorsement form is for NGOs and businesses only. A separate form for individuals will be circulated in the near future.

The No Toxics in Food Packaging Act of 2026:

  1. bans the uses of PFAS (class), Ortho-phthalates (class), Bisphenols (A, B, S, F, AF or related compounds) which are carcinogens, reproductive toxicants, hormone disrupting compounds and more
  2. bans the uses of the following carcinogens:  
  • Acrylamide
  • BHA
  • Chlorinated paraffins
  • 1,4 – dioxane
  • Asbestos
  • Benzene
  • Chloroform
  • Methylene chloride
  • Ethylene oxide
  • Formaldehyde
  • Styrene polymers


3. bans these chemicals by explicitly deeming them unsafe to use as food contact substances through amendment of the Federal Food, Drug and Cosmetic Act (Section 409, 21 U.S.C. 348)

4. applies to re-useable food containers.

5. addresses regrettable substitution by requiring the FDA, when assessing alternative chemicals, to consider their effects on vulnerable populations – those with potential for disproportionate exposure to or disproportionate adverse effects from chemicals or mixtures, including

  • residents in communities subject to disproportionate exposures.
  • workers;
  • individuals with preexisting medical conditions;
  • the elderly;
  • pregnant women;
  • infants, children, and adolescents;

Please sign on here by May 29. We will continue to take sign ons after that date, but organizations endorsing by this deadline will be publicized at bill introduction.

Thank you in advance for your support. Please feel free to contact me at Lisette@bcpp.org with your questions. Thank you!